drugset / Trial / NCT00578201
FOLFOX-Cetuximab-radiotherapy for the Treatment of Esophageal Cancer
Phase 2
Completed
80 enrolled
Assistance Publique - Hôpitaux de Paris
GERCOR - Multidisciplinary Oncology Cooperative Group · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This phase II trial is studying the effects of oxaliplatin, leucovorin and fluorouracil-when given together with Cetuximab and radiation therapy and radiation therapy to see how they work in treating patients with stage III esophageal cancer.
Timeline
- Start
- 2007-11
- Primary completion
- 2011-02
- Completion
- 2011-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cetuximab | Monoclonal antibody | — | — |
| Subject | Leucovorin | Small molecule | — | — |
| Subject | Oxaliplatin | Small molecule | — | — |
| Subject | fluorouracil | Small molecule | — | — |